This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Gilead Connecticut, Inc., Gilead Pharmasset LLC. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Burlingame, CA (US) (2014 - 2017)
- Hayward, CA (US) (2016 - 2018)
- Foster City, CA (US) (2016 - 2018)
Company Filing History:
Years Active: 2014-2018
Title: Melissa Jean Casteel: Innovator in Pharmaceutical Compositions
Introduction
Melissa Jean Casteel is a prominent inventor based in Hayward, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the formulation of Syk inhibitors. With a total of 6 patents to her name, her work has had a considerable impact on drug development.
Latest Patents
Among her latest patents, Casteel has disclosed pharmaceutical compositions that comprise a compound with a specific formula or a pharmaceutically acceptable salt thereof. These compositions also include at least one pharmaceutically acceptable polymer. The salts can be mesylate salts, such as mono-mesylate or bis-mesylate salts, or their hydrates. Additionally, she has outlined methods of use for these pharmaceutical compositions, showcasing her innovative approach to drug formulation.
Career Highlights
Casteel has worked with notable companies in the pharmaceutical industry, including Gilead Pharmasset LLC and Gilead Connecticut, Inc. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects.
Collaborations
Some of her notable coworkers include Dimitrios Stefanidis and Rowchanak Pakdaman. Their collaborative efforts have contributed to the advancement of pharmaceutical innovations.
Conclusion
Melissa Jean Casteel is a distinguished inventor whose work in pharmaceutical compositions continues to influence the industry. Her innovative formulations and collaborations highlight her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile